ACCURAY INCORPORATED Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31)
ACCURAY INCORPORATED (ARAY) reported Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) of $29.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-03.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses · last filed 2017-11-03
- ACCURAY INCORPORATED available-for-sale securities, continuous unrealized loss position, 12 months or longer, aggregate loss (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $29.00K, a 31.82% increase year-over-year.
- ACCURAY INCORPORATED available-for-sale securities, continuous unrealized loss position, 12 months or longer, aggregate loss (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $53.00K.
- ACCURAY INCORPORATED available-for-sale securities, continuous unrealized loss position, 12 months or longer, aggregate loss (deprecated 2018-01-31) for the quarter ending 2017-03-31 was -$68.00K.
- ACCURAY INCORPORATED available-for-sale securities, continuous unrealized loss position, 12 months or longer, aggregate loss (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $51.00K.
- ACCURAY INCORPORATED available-for-sale securities, continuous unrealized loss position, 12 months or longer, aggregate loss (deprecated 2018-01-31) for fiscal 2016 was $20.00K, a 41.18% decline from fiscal 2015.
- ACCURAY INCORPORATED available-for-sale securities, continuous unrealized loss position, 12 months or longer, aggregate loss (deprecated 2018-01-31) for fiscal 2015 was $34.00K.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-09-30 | $29.00K 10-Q · filed 2017-11-03 | $82.00K derived: sum of 2 quarters · filed 2017-11-03 | $14.00K derived: sum of 3 quarters · filed 2017-11-03 | $65.00K derived: sum of 4 quarters · filed 2017-11-03 |
| 2017-06-30 | $53.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2017-11-03 | -$15.00K derived: sum of 2 quarters · filed 2017-11-03 | $36.00K derived: sum of 3 quarters · filed 2017-11-03 | $58.00K 10-Q · filed 2017-11-03 |
| 2017-03-31 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-05 | -$17.00K derived: sum of 2 quarters · filed 2017-05-05 | $5.00K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-03 | $73.00K 10-Q · filed 2017-02-03 | ||
| 2016-09-30 | $22.00K 10-Q · filed 2016-11-01 | |||
| 2016-06-30 | $20.00K 10-K · filed 2017-08-25 | |||
| 2015-06-30 | $34.00K 10-K · filed 2016-08-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |